Orthofix International N.V., (NASDAQ:OFIX) announced today that it will
participate in the UBS Global Life Sciences Conference.
Vice President of Investor Relations Dan Yarbrough is scheduled to give
a presentation on Thursday, September 25th, at
8:30 AM Eastern Time at The Grand Hyatt in New York.
A live audio webcast of the presentation will be available on the company’s
website at www.orthofix.com.
About Orthofix International, N.V.
Orthofix International N.V., a global medical device company, offers a
broad line of minimally invasive surgical, as well as non-surgical,
products for the spine, orthopedic, and sports medicine market sectors
that address the lifelong bone-and-joint health needs of patients of all
ages, helping them achieve a more active and mobile lifestyle. Orthofix’s
products are widely distributed around the world to orthopedic surgeons,
hospitals and patients via Orthofix’s sales
representatives and its subsidiaries, including Breg, Inc. and
Blackstone Medical, Inc. In addition, Orthofix is collaborating in R&D
partnerships with leading medical institutions such as the Orthopedic
Research and Education Foundation, the Cleveland Clinic Foundation, and
the National Osteoporosis Institute. For more information about
Orthofix, please visit www.orthofix.com.
Orthofix
Dan Yarbrough, 617-912-2903
Vice President of
Investor Relations
danyarbrough@orthofix.com
